Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantation

Clinical trial NCT05754242 · UNKNOWN

Trial details

NCT number: NCT05754242
Sponsor: Hospital Universitario Ramon y Cajal
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Transplantation Postreperfusion Syndrome Ascorbic Acid

Start date: 2020-11-17
Primary completion: 2023-06-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.